Country: United States

Sonosite, operating as FUJIFILM Sonosite, Inc., is a US-based manufacturer that researches, develops, and produces point-of-care ultrasound (POCUS) systems, transducers, software, and related imaging technologies. Established in 1998 as SonoSite, Inc. and headquartered in Bothell, Washington, the company has been part of the FUJIFILM Group since 2012, drawing on more than 25 years of pioneering experience in bedside ultrasound and standing as the world leader in point-of-care ultrasound solutions. Its comprehensive product portfolio has evolved through several generations of portable ultrasound machines, with signature offerings including the Sonosite PX, SII, Edge II, X-Porte, iViz, and the newly launched Sonosite MT introduced in November 2025, complemented by an extensive line of transducers such as the L25xp, L38xi, L38xp, P10x, P10xp, P21v, and P21x, along with a wide range of accessories, voice assist software, cleaners, and after-sales services designed to support clinicians in diverse care environments.

Backed by decades of digital ultrasound expertise and integrated circuit engineering that originally traced back to DARPA-funded research, Sonosite combines refined technology with rigorous quality control to deliver equipment that meets the highest healthcare standards. The company launched the world's first point-of-care ultrasound machine, the Sonosite 180, in 1998, revolutionising the way ultrasound could be brought to any patient, in any environment. Since then, it has continued to introduce groundbreaking innovations including SonoHD2 and SonoMB imaging technologies, Pulse Inversion THI signal processing, the HFL38xi dualflex transducer, thin lens transducer design, the industry's first ASIC for ultrasound miniaturisation, and the Vevo MD ultra-high frequency ultrasound system. More recent milestones include the launch of the Sonosite PX in 2023 and the introduction of Sonosite Voice Command in 2024, reflecting the company's dedication to portability, image optimisation, intuitive controls, and consistent clinical reliability.

Serving hospitals, emergency departments, critical care units, anesthesiology teams, radiologists, cardiologists, vascular specialists, obstetricians and gynaecologists, paediatricians, surgeons, physical therapists, and veterinary practitioners around the world, Sonosite delivers ultrasound solutions designed for use in a wide range of clinical applications from vascular access and musculoskeletal medicine to perioperative care and ultrasound-guided nerve blocks. With a global commercial footprint and a reputation as the most adopted and trusted point-of-care ultrasound brand, the company emphasises innovation, customer success, and continuous product refinement. Guided by its long-standing vision to improve patient outcomes and elevate quality of care, Sonosite positions itself as a trusted American partner for clinicians seeking durable, mobile, and reliable ultrasound solutions worldwide.